AdaptHealth Q1 revenue +5.4% to $744.6M; adjusted EBITDA -2.7% to $134M

AdaptHealth Corp.

2023-Q1 EPS reported -$0.06 revenue$744,626,000

Net revenue $744.6M, up 5.4% YoY; non-acquired growth 4.7%.
Adjusted EBITDA $134.0M, down 2.7% from $137.6M in Q1 2022.
Sleep category revenue grew 17.6% YoY; Diabetes business declined.
Net income attributable to AdaptHealth Corp. was $15.7M.
Company launched cost management program to revamp supply chain and real estate.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

AdaptHealth Corp. reported first quarter ended March 31, 2023 results: revenue Net revenue was $744.6 million, net income Net income attributable to AdaptHealth Corp. was $15.7 million.

Period: first quarter ended March 31, 2023
Revenue: Net revenue was $744.6 million
Net income: Net income attributable to AdaptHealth Corp. was $15.7 million
Result: reported results

Exact text from the filing

medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2023. First Quarter Results and Highlights • Net revenue was $744.6 million compared to $706.2 million in the first quarter of 2022, an increase of 5.4%, including 17.6% growth in our Sleep categories. • Non-acquired growth was 4.7%. • Net income

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

AdaptHealth Corp. filing history →

Source: SEC EDGAR

accession 0001628280-23-016626

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.